TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $2.65M invested in Titan Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-9
Holders Change %
-37.5%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
1
Closed
10
Calls
$1.35M
Puts
$59K
Net Calls
+$1.29M
Net Calls Change
+$1.28M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$191K |
| 3 |
SIM
Spark Investment Management
New York
|
+$87.6K |
| 4 |
Bank of New York Mellon
New York
|
+$67.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$48.9K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$3.38M |
| 2 |
PA
Perceptive Advisors
New York
|
-$2.32M |
| 3 |
Millennium Management
New York
|
-$277K |
| 4 |
Renaissance Technologies
New York
|
-$275K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$225K |
